November 29, 2011
Bristol-Myers K.K. (BMKK) announced on November 28 that its anticancer drug Paraplatin Injection 50 mg, 150 mg, and 450 mg (carboplatin) obtained approval for an additional indication and dosage for breast cancer on November 25. At a meeting in April,...read more